Finance

Lists
Why is KREBSBIO down 5,03%?
Dive Deeper
KREBSBIO:NSE
Krebs Biochemicals And Industries Ltd
57,16 INR
-5,03%
(-3,03) 1D
19 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for KREBSBIO...
Open
60,80 INR
High
60,80 INR
Low
57,10 INR
Mkt. cap
1,25 მლრდ.
Avg. vol.
45,28 ათ.
Volume
4,54 ათ.
52-wk high
76,85 INR
52-wk low
38,33 INR
EPS
-6,53 INR
Shares outstanding
13,74 მლნ.
No. of employees
142
Open
60,80 INR
High
60,80 INR
Low
57,10 INR
Mkt. cap
1,25 მლრდ.
Avg. vol.
45,28 ათ.
Volume
4,54 ათ.
52-wk high
76,85 INR
52-wk low
38,33 INR
EPS
-6,53 INR
Shares outstanding
13,74 მლნ.
No. of employees
142
News stories
From web sources and news partners
About Krebs Biochemicals And Industries Ltd
CEO-
Employees142
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitekrebsbiochem.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
41,67 მლნ.
72,74 მლნ.
68,09 მლნ.
69,84 მლნ.
Cost of goods sold
16,00 ათ.
17,00 ათ.
10,28 მლნ.
4,11 მლნ.
Cost of revenue
16,00 ათ.
17,00 ათ.
10,28 მლნ.
4,11 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,90 მლნ.
26,92 მლნ.
26,26 მლნ.
27,79 მლნ.
Operating expense
85,76 მლნ.
86,06 მლნ.
63,31 მლნ.
71,77 მლნ.
Total operating expenses
85,77 მლნ.
86,08 მლნ.
73,59 მლნ.
75,88 მლნ.
Operating income
-44,10 მლნ.
-13,34 მლნ.
-5,50 მლნ.
-6,04 მლნ.
Other non operating income
-
-1,00 ათ.
18,53 მლნ.
-
EBT including unusual items
-61,43 მლნ.
-31,26 მლნ.
-23,40 მლნ.
-24,85 მლნ.
EBT excluding unusual items
-61,43 მლნ.
-31,26 მლნ.
-4,60 მლნ.
-24,85 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
42,62 მლნ.
42,79 მლნ.
21,39 მლნ.
28,10 მლნ.
Net income
-61,43 მლნ.
-31,26 მლნ.
-23,40 მლნ.
-24,85 მლნ.
Net profit margin
-147,40%
-42,98%
-34,36%
-35,58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,46 მლნ.
-
Interest expense
-17,33 მლნ.
-17,93 მლნ.
-19,09 მლნ.
-18,80 მლნ.
Net interest expenses
-17,33 მლნ.
-17,93 მლნ.
-17,63 მლნ.
-18,80 მლნ.
Depreciation and amortization charges
16,24 მლნ.
16,35 მლნ.
15,66 მლნ.
15,88 მლნ.
EBITDA
-27,98 მლნ.
2,93 მლნ.
10,10 მლნ.
10,02 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები